failure to respond or late response
on 17 Dec 2021
Last Applicant/ Owned by
40221 Düsseldorf
DE
Serial Number
79288683 filed on 26th Feb 2020
Registration Number
N/A
Correspondent Address
Bruce Londa
Filing Basis
No Filing Basis
Disclaimer
NO DATA
The mark consists of multiple blue dots, being light blue in the middle and getting progressively darker toward the outside, some connected with curved lines, forming a spiral shape. The word "CELLVIE" sits underneath the spiral in grey. Preparations for medical purposes employing mitochondria; cardiovascular treatment preparations employing mitochondria; cardiovascular pharmaceuticals employing Read More
Preparations for medical purposes employing mitochondria; cardiovascular treatment preparations employing mitochondria; cardiovascular pharmaceuticals employing mitochondria used in treating arrhythmias; pharmaceutical and biological preparations for the treatment of cardiovascular diseases, ischemia-and reperfusion-injuries, chronic cardiac diseases, mitochondrial myopathies, tumors or diabetes mitochondria for transplant purposes for medical use; pharmaceutical and biological preparations for the application of mitochondria transplantation for medical purposes in vessel and organ transplantations; implantable living tissue and mitochondria for the promotion of tissue growth, for medical use; mitochondria, for medical use; biological tissue cultures containing mitochondria for medical purposes; pharmaceutical and biological preparations containing mitochondria for tissue regeneration and protection for medical purposes; living cell components, namely, mitochondria, including genetically-modified mitochondria or pharmaceutically treated mitochondria, for medical use in humans and veterinary use in animals
Prosthetic tissues based on mitochondria for parietal, vascular and visceral use; medical apparatus and devices for the processing of tissue- or cell-samples for the isolation of mitochondria or other cell components, namely, nucleus, ribosomes, rough endoplasmic reticulum, smooth endoplasmic reticulum, golgi apparatus, vacuole, chloroplasts, peroxisome, lysosome, centrosome, centriole, cilium, microvillus, cytosol, cytoskeleton, microtubules, filaments, exosomes, deoxyribonucleic acid (DNA), ribonucleic acid (RNA), micro RNA (mRNA), transfer RNA (tRNA), nucleic acid, cell membrane, plasma membrane and secretory vesicles from muscle tissue or other human or animal tissues, as well as from cells and cell cultures; filter for the isolation of cell components, namely, mitochondria, nucleus, ribosomes, rough endoplasmic reticulum, smooth endoplasmic reticulum, golgi apparatus, vacuole, chloroplasts, peroxisome, lysosome, centrosome, centriole, cilium, microvillus, cytosol, cytoskeleton, microtubules, filaments, exosomes, deoxyribonucleic acid (DNA), ribonucleic acid (RNA), micro RNA (mRNA), transfer RNA (tRNA), nucleic acid, cell membrane, plasma membrane and secretory vesicles from cells for medical purposes; medical apparatus and devices for the transplantation or injection of cells or cell component, namely, mitochondria, nucleus, ribosomes, rough endoplasmic reticulum, smooth endoplasmic reticulum, golgi apparatus, vacuole, chloroplasts, peroxisome, lysosome, centrosome, centriole, cilium, microvillus, cytosol, cytoskeleton, microtubules, filaments, exosomes, deoxyribonucleic acid (DNA), ribonucleic acid (RNA), micro RNA (mRNA), transfer RNA (tRNA), nucleic acid, cell membrane, plasma membrane and secretory vesicles in humans or animals
Scientific and technological services, namely, scientific and clinical research, analysis and testing in the field of mitochondrial isolation or transplantation; scientific and clinical research and development services in the field of mitochondria; conducting clinical trials for others in the field of cardiovascular diseases, ischemia-and reperfusion-injuries, heart transplantations, tumor treatments, mitochondrial myopathies analysis of human tissues for scientific and clinical research relating to mitochondria; scientific and clinical research, analysis and testing services relating to the isolation and cultivation of human and animal mitochondria
Medical testing services for diagnostic and disease treatment purposes relating to cardiovascular diseases, ischemia-and reperfusion-injuries, chronic cardiac diseases, mitochondrial myopathies and tumors; medical analysis of human or animal tissues for mitochondria transplant treatment purposes of cardiovascular diseases, ischemia-and reperfusion-injuries, chronic cardiac diseases, mitochondrial myopathies and tumors; medical analysis of cells and cell components in relation to mitochondria for diagnostic and treatment purposes of cardiovascular diseases, ischemia-and reperfusion-injuries, chronic cardiac diseases, mitochondrial myopathies and tumors
No 79288683
No Service Mark
No 116562-14
No
No
No
No
No
No
No
No
26.01.21 -
Circles that are totally or partially shaded
26.01.31 -
Five or more circles
26.17.01 -
Straight line(s), band(s) or bar(s)
26.17.06 -
Diagonal line(s), band(s) or bar(s)
The mark consists of multiple blue dots, being light blue in the middle and getting progressively darker toward the outside, some connected with curved lines, forming a spiral shape. The word "CELLVIE" sits underneath the spiral in grey.
| Status Date | Action Taken |
|---|---|
| 09th Jan 2023 | FINAL DECISION TRANSACTION PROCESSED BY IB |
| 19th Dec 2022 | FINAL DISPOSITION NOTICE SENT TO IB |
| 17th Dec 2022 | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB |
| 25th Dec 2021 | NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB |
| 17th Dec 2021 | ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND |
| 17th Dec 2021 | ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE |
| 08th Dec 2021 | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB |
| 08th Dec 2021 | NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB |
| 05th Jun 2021 | NOTIFICATION OF FINAL REFUSAL EMAILED |
| 05th Jun 2021 | FINAL REFUSAL E-MAILED |
